NeoGenomics is trading at $19.92, up 4.11% from its $19.13 previous close; broader-market support is possible, not confirmed. - Nasdaq Composite is up 0.61%; S&P 500, 0.45%. - October 5: preliminary Q3 revenue was about $209 million, with NGS growth of 28% year over year; full-year guidance was reiterated. - Warren Stone was named next CEO, effective January 4, 2027. Reports linked the announcement and lack of a guidance increase to after-hours selling, not the current pre-market rise.